Navigating the “No Man's Land” of TKI-Failed EGFR-Mutated Non–Small Cell Lung Cancer (NSCLC): A Review
As the leading cause of cancer-related mortality, lung cancer is a worldwide health issue that is overwhelmingly caused by smoking. However, a substantial minority (~25%) of patients with non–small cell lung cancer (NSCLC) has never smoked. In these patients, activating mutations of the epidermal gr...
Main Authors: | Bryan Oronsky, Patrick Ma, Tony R. Reid, Pedro Cabrales, Michelle Lybeck, Arnold Oronsky, Neil Oronsky, Corey A. Carter |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558617304700 |
Similar Items
-
Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance
by: Bryan Oronsky, et al.
Published: (2015-09-01) -
What's New in SCLC? A Review
by: Bryan Oronsky, et al.
Published: (2017-10-01) -
No patient left behind: The promise of immune priming with epigenetic agents
by: Corey A. Carter, et al.
Published: (2017-10-01) -
A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis
by: Bryan Oronsky, et al.
Published: (2018-06-01) -
Rewriting the Epigenetic Code for Tumor Resensitization: A Review
by: Bryan Oronsky, et al.
Published: (2014-10-01)